These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7913539

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Remoxipride and raclopride differentially alter the activity of incertohypothalamic dopaminergic neurons.
    Eaton MJ, Tian Y, Lookingland KJ, Moore KE.
    Neuropharmacology; 1992 Nov; 31(11):1121-6. PubMed ID: 1475021
    [Abstract] [Full Text] [Related]

  • 8. In vivo effects of remoxipride and aromatic ring metabolites in the rat.
    Ahlenius S, Ericson E, Hillegaart V, Nilsson LB, Salmi P, Wijkström A.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1356-66. PubMed ID: 9400011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.
    Johansson C, Jackson DM, Svensson L.
    Psychopharmacology (Berl); 1994 Dec; 116(4):437-42. PubMed ID: 7701046
    [Abstract] [Full Text] [Related]

  • 11. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
    Westlind-Danielsson A, Gustafsson K, Andersson I.
    Eur J Pharmacol; 1994 Dec 15; 288(1):89-95. PubMed ID: 7705472
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987 Dec 15; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats.
    Guinetdinov RR, Bogdanov MB, Pogorelov VM, Kudrin VS, Rayevsky KS.
    Neuropharmacology; 1991 Nov 15; 30(11):1251-4. PubMed ID: 1685561
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
    Ericson H, Ross SB.
    Eur J Pharmacol; 1992 Jun 05; 226(2):157-61. PubMed ID: 1353452
    [Abstract] [Full Text] [Related]

  • 18. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats.
    See RE, Chapman MA, Meshul CK.
    Synapse; 1992 Oct 05; 12(2):147-54. PubMed ID: 1362290
    [Abstract] [Full Text] [Related]

  • 19. [A comparative study of the neurochemical profiles of carbidine stereoisomers].
    Gaĭnetdinov RR, Miroshnichenko II, Kudrin VS, Bogdanov MB, Pogorelov VM, Budygin EA, Kovalev GI, Raevskiĭ KS.
    Eksp Klin Farmakol; 1993 Oct 05; 56(1):24-7. PubMed ID: 8100728
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.